Puff Puff Post

DECEMBER 28, 2018

A sample of 120 patients aged between 5 and 29 years old with mild to severe autism are currently being given two different cannabis oil formulas or placebo. The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

DECEMBER 23, 2021

billion by 2025. However, no single cannabinoid drug has received widespread approval in the treatment of pain. The market sizing section provides forecasts on the estimated sales of the three most lucrative cannabinoid pharmaceuticals – from 2021-2025 – including Epidiolex, Sativex and Dronabinol.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

SpeedWeed

MARCH 19, 2021

Regular doses of CBD could help prevent cognitive decline in Alzheimer’s patients, according to a new study recently published in the Journal of Alzheimer’s Disease. AD is now the 6th leading cause of death in the US, but there is no treatment on the market that can prevent, cure, or even slow the spread of this disease.

CBD 52

CBD Clinical Trials Treatment Therapy 52

Cannabis Law Report

NOVEMBER 16, 2021

Our treatment designed for delaying aging has a distinctive drug profile of oral delivery, selectivity, and very low toxicity as compared with TNF blockers, all of which are delivered by injection only. “For The secondary measures will be the safety, tolerability, and pharmacokinetics in this population of patients.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JANUARY 5, 2022

“This patent issuance is rewarding and timely as we launch our Phase 2 trial of MYMD-1 as a therapy for sarcopenia, frailty, and aging, which is currently recruiting patients,” said Chris Chapman, M.D., President, Director and Chief Medical Officer of MyMD.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

JUNE 25, 2021

billion in 2025 at a CAGR of 14%. EMA also regulates and supervises the drug quality, check for the intended use of the drug and whether the drug is meeting the requirement of clinical trial. MorphoSys and LEO Pharma strategically worked together to develop antibodies pertaining to the treatment of skin cancer.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

Cannabis Law Report

JULY 15, 2022

“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.

Medicine 52

Medicine Patients Media Supply Chain 52